Shares of Tabula Rasa HealthCare Inc (NASDAQ:TRHC) have earned an average rating of “Buy” from the fourteen brokerages that are covering the firm, Marketbeat Ratings reports. Two research analysts have rated the stock with a hold recommendation and twelve have issued a buy recommendation on the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $82.27.
Several research analysts have recently commented on the company. Cantor Fitzgerald reissued a “buy” rating and issued a $99.00 target price on shares of Tabula Rasa HealthCare in a report on Tuesday, November 6th. Zacks Investment Research raised Tabula Rasa HealthCare from a “sell” rating to a “hold” rating in a report on Thursday, December 6th. Piper Jaffray Companies reissued an “overweight” rating and issued a $80.00 target price on shares of Tabula Rasa HealthCare in a report on Thursday, December 6th. BidaskClub downgraded Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a report on Tuesday, December 18th. Finally, Chardan Capital boosted their target price on Tabula Rasa HealthCare from $77.00 to $91.00 and gave the stock a “buy” rating in a report on Wednesday, November 7th.
In other news, President Orsula V. Knowlton acquired 7,500 shares of Tabula Rasa HealthCare stock in a transaction on Monday, November 12th. The shares were purchased at an average price of $65.00 per share, with a total value of $487,500.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, President Orsula V. Knowlton sold 8,000 shares of the company’s stock in a transaction on Wednesday, October 17th. The stock was sold at an average price of $81.01, for a total value of $648,080.00. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 63,790 shares of company stock worth $4,409,251. Company insiders own 14.00% of the company’s stock.
TRHC stock opened at $66.00 on Friday. Tabula Rasa HealthCare has a 1-year low of $28.55 and a 1-year high of $91.16. The company has a market capitalization of $1.35 billion, a PE ratio of -1,650.00, a P/E/G ratio of 4.20 and a beta of 2.45. The company has a debt-to-equity ratio of 0.28, a quick ratio of 0.46 and a current ratio of 0.49.
Tabula Rasa HealthCare (NASDAQ:TRHC) last announced its earnings results on Tuesday, November 6th. The company reported $0.26 EPS for the quarter, topping the consensus estimate of $0.19 by $0.07. The business had revenue of $54.42 million for the quarter, compared to the consensus estimate of $52.87 million. Tabula Rasa HealthCare had a positive return on equity of 7.63% and a negative net margin of 13.49%. Tabula Rasa HealthCare’s revenue was up 66.3% compared to the same quarter last year. During the same period in the previous year, the business earned $0.08 EPS. Analysts forecast that Tabula Rasa HealthCare will post 0.42 earnings per share for the current year.
Tabula Rasa HealthCare Company Profile
Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.
Read More: Bull Market
Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.